The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Senchenko M.A.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Konovalov D.M.

Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

IgD expression in various immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma in children

Authors:

Senchenko M.A., Konovalov D.M.

More about the authors

Read: 1158 times


To cite this article:

Senchenko MA, Konovalov DM. IgD expression in various immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma in children. Russian Journal of Archive of Pathology. 2024;86(1):21‑26. (In Russ.)
https://doi.org/10.17116/patol20248601121

References:

  1. Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJ, Klapper W, Falini B, von Heydebreck A, Metzler D, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205(10):2251-2268. https://doi.org/10.1084/jem.20080809
  2. Mottok A, Renné C, Willenbrock K, Hansmann ML, Bräuninger A. Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood. 2007;110(9):3387-3390. https://doi.org/10.1182/blood-2007-03-082511
  3. Falini B, Bigerna B, Pasqualucci L, Fizzotti M, Martelli MF, Pileri S, Pinto A, Carbone A, Venturi S, Pacini R, et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin’s disease. Blood. 1996;87(2):465-471.  https://doi.org/10.1182/blood.v87.2.465.bloodjournal872465
  4. Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E, Poppema S, Harris M, Franssila K, van Krieken J, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin’s disease and lymphocyte-rich classical Hodgkin’s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin’s Disease. J Clin Oncol. 1999;17(3):776-783.  https://doi.org/10.1200/JCO.1999.17.3.776
  5. Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27(10):1346-1356. https://doi.org/10.1097/00000478-200310000-00007
  6. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. IARC: Lyon, France; 2017;588. 
  7. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-Cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-Cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol. 2003;120(5):767-777.  https://doi.org/10.1309/YCH8-DWUF-FQBK-GPVB
  8. Herbeck R, Teodorescu Brînzeu D, Giubelan M, Lazǎr E, Dema A, Ioniţǎ H. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. Rom J Morphol Embryol. 2011;52(1):69-74. 
  9. Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol. 2006;30(5):585-592.  https://doi.org/10.1097/01.pas.0000194741.87798.45
  10. Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, et al. Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2018;65(1):10.1002/pbc.26753. https://doi.org/10.1002/pbc.26753
  11. Shankar AG, Kirkwood AA, Hall GW, Hayward J, O’Hare P, Ramsay AD. Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma — a review of clinical outcome based on the histological variants. Br J Haematol. 2015;171(2):254-262.  https://doi.org/10.1111/bjh.13540
  12. Hartmann S, Eichenauer DA, Plütschow A, Mottok A, Bob R, Koch K, Bernd HW, Cogliatti S, Hummel M, Feller AC, et al. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma — a matched pair analysis from the German Hodgkin Study Group (GHSG). Br J Haematol. 2014;167(2):238-242.  https://doi.org/10.1111/bjh.12997
  13. Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, et al. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95(4):1443-1450. https://doi.org/10.1182/blood.V95.4.1443.004k55_1443_1450

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.